{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:43:56Z","timestamp":1794667436206,"version":"4.9.1"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Dalian Major Basic Research Projects","award":["No. 2023JJ11CG005"],"award-info":[{"award-number":["No. 2023JJ11CG005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01932-2","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T09:56:15Z","timestamp":1765965375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recent molecular insights and biosensor-based diagnostic technologies for hyperphosphorylated Tau in Alzheimer's disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Samah","family":"Shabana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed I.","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angyang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5375-0505","authenticated-orcid":false,"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"1932_CR1","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/antiox12081628","volume":"12","author":"G Plascencia-Villa","year":"2023","unstructured":"Plascencia-Villa G, Perry G, MDPI AG. Roles of oxidative stress in synaptic dysfunction and neuronal cell death in Alzheimer\u2019s disease. Antioxidants. 2023;12:1628. https:\/\/doi.org\/10.3390\/antiox12081628.","journal-title":"Antioxidants"},{"key":"1932_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1430465","author":"Y Cao","year":"2024","unstructured":"Cao Y, Zhao L-W, Chen Z-X, Li S-H, Front Media SA. New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer\u2019s disease. Front Neurosci. 2024. https:\/\/doi.org\/10.3389\/fnins.2024.1430465.","journal-title":"Front Neurosci"},{"key":"1932_CR3","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/biom15060824","volume":"15","author":"X Hong","year":"2025","unstructured":"Hong X, Huang L, Lei F, Li T, Luo Y, Zeng M, et al. The role and pathogenesis of Tau protein in Alzheimer\u2019s disease. Biomolecules. 2025;15:824. https:\/\/doi.org\/10.3390\/biom15060824.","journal-title":"Biomolecules"},{"key":"1932_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00465-0","author":"MM Rahman","year":"2021","unstructured":"Rahman MM, Lendel C, Springer Science and Business Media LLC. Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology. Mol Neurodegener. 2021. https:\/\/doi.org\/10.1186\/s13024-021-00465-0.","journal-title":"Mol Neurodegener"},{"key":"1932_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41593-024-01829-7","volume":"28","author":"N Watamura","year":"2025","unstructured":"Watamura N, Foiani MS, Bez S, Bourdenx M, Santambrogio A, Frodsham C, et al. In vivo hyperphosphorylation of tau is associated with synaptic loss and behavioral abnormalities in the absence of tau seeds. Nat Neurosci. 2025;28:293\u2013307. https:\/\/doi.org\/10.1038\/s41593-024-01829-7. Springer Science and Business Media LLC.","journal-title":"Nat Neurosci"},{"key":"1932_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/brain\/awae234","volume":"148","author":"J Appleton","year":"2025","unstructured":"Appleton J, Finn Q, Zanotti-Fregonara P, Yu M, Faridar A, Nakawah MO, et al. Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer\u2019s disease. Brain. 2025;148:119\u201332. https:\/\/doi.org\/10.1093\/brain\/awae234. Oxford University Press (OUP).","journal-title":"Brain"},{"key":"1932_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2024.101800","volume":"39","author":"H Wada","year":"2024","unstructured":"Wada H, Maruyama T, Niikura T. SUMO1 modification of 0N4R-tau is regulated by PIASx, SENP1, SENP2, and TRIM11. Biochem Biophys Rep. 2024;39:101800. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101800.","journal-title":"Biochem Biophys Rep"},{"issue":"3","key":"1932_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/jnc.16053","volume":"168","author":"J Zhang","year":"2024","unstructured":"Zhang J, Fang Z, Zhao J, Liu G, Shen X, Jiang G, et al. Acetylated tau exacerbates apoptosis by disturbing mitochondrial dynamics in HEK293 cells. J Neurochem. 2024;168(3):288\u2013302. https:\/\/doi.org\/10.1111\/jnc.16053.","journal-title":"J Neurochem"},{"key":"1932_CR9","doi-asserted-by":"publisher","unstructured":"Bryan Iii MR, Tian X, Tseng J-H, Evangelista BA, Ragusa JV, Bryan AF, et al. Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer\u2019s disease. acta neuropathol commun. Springer Science and Business Media LLC; 2024;12. https:\/\/doi.org\/10.1186\/s40478-024-01865-1","DOI":"10.1186\/s40478-024-01865-1"},{"key":"1932_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101766","volume":"298","author":"N Puangmalai","year":"2022","unstructured":"Puangmalai N, Sengupta U, Bhatt N, Gaikwad S, Montalbano M, Bhuyan A, et al. Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer\u2019s disease. J Biol Chem. 2022;298:101766. https:\/\/doi.org\/10.1016\/j.jbc.2022.101766.","journal-title":"J Biol Chem"},{"key":"1932_CR11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/s1474-4422(21)00214-3","volume":"20","author":"EH Thijssen","year":"2021","unstructured":"Thijssen EH, La Joie R, Strom A, Fonseca C, Iaccarino L, Wolf A, et al. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol. 2021;20:739. https:\/\/doi.org\/10.1016\/s1474-4422(21)00214-3.","journal-title":"Lancet Neurol"},{"key":"1932_CR12","doi-asserted-by":"publisher","unstructured":"Janelidze S, Mattsson N, Smith R, Stomrud E, Palmqvist S, Dage JL, et al. Plasma phospho\u2010tau217 is a potential early diagnostic and prognostic biomarker of Alzheimer\u2019s disease: biomarkers (non\u2010neuroimaging) \/ plasma\/serum\/urine biomarkers. Alzheimers Dement. 2020. https:\/\/doi.org\/10.1002\/alz.042489.","DOI":"10.1002\/alz.042489"},{"key":"1932_CR13","doi-asserted-by":"publisher","unstructured":"Leuzy A, Bollack A, Pellegrino D, Teunissen CE, La Joie R, Rabinovici GD, et al. Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer\u2019s disease. Alzheimers Dement. 2025. https:\/\/doi.org\/10.1002\/alz.14528.","DOI":"10.1002\/alz.14528"},{"key":"1932_CR14","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1039\/c8an00527c","volume":"143","author":"B Shui","year":"2018","unstructured":"Shui B, Tao D, Cheng J, Mei Y, Jaffrezic-Renault N, Guo Z. A novel electrochemical aptamer\u2013antibody sandwich assay for the detection of tau-381 in human serum. Analyst. 2018;143:3549\u201354. https:\/\/doi.org\/10.1039\/c8an00527c.","journal-title":"Analyst"},{"key":"1932_CR15","doi-asserted-by":"publisher","first-page":"108057","DOI":"10.1016\/j.bioelechem.2022.108057","volume":"145","author":"M Eduarda Schneider","year":"2022","unstructured":"Eduarda Schneider M, Guillade L, Correa-Duarte MA, Moreira FTC. Development of a biosensor for phosphorylated Tau 181 protein detection in early-stage Alzheimer\u2019s disease. Bioelectrochemistry. 2022;145:108057. https:\/\/doi.org\/10.1016\/j.bioelechem.2022.108057. Elsevier BV.","journal-title":"Bioelectrochemistry"},{"key":"1932_CR16","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/bios13070742","volume":"13","author":"A Sharma","year":"2023","unstructured":"Sharma A, Angnes L, Sattarahmady N, Negahdary M, Heli H. Electrochemical immunosensors developed for amyloid-beta and tau proteins, leading biomarkers of Alzheimer\u2019s disease. Biosensors. 2023;13:742. https:\/\/doi.org\/10.3390\/bios13070742.","journal-title":"Biosensors"},{"key":"1932_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/coatings13020235","volume":"13","author":"E Miku\u0142a","year":"2023","unstructured":"Miku\u0142a E, Malecka-Baturo K, MDPI AG. An overview of the latest developments in the electrochemical aptasensing of neurodegenerative diseases. Coatings. 2023;13:235. https:\/\/doi.org\/10.3390\/coatings13020235.","journal-title":"Coatings"},{"key":"1932_CR18","doi-asserted-by":"publisher","first-page":"115174","DOI":"10.1016\/j.bios.2023.115174","volume":"228","author":"SH Ciou","year":"2023","unstructured":"Ciou SH, Hsieh AH, Lin YX, Sei JL, Govindasamy M, Kuo CF, et al. Sensitive label-free detection of the biomarker phosphorylated tau protein in Alzheimer\u2019s disease using a graphene-based solution-gated field effect transistor. Biosensors Bioelectr. 2023;228:115174. https:\/\/doi.org\/10.1016\/j.bios.2023.115174. Elsevier BV.","journal-title":"Biosensors Bioelectr"},{"key":"1932_CR19","doi-asserted-by":"publisher","unstructured":"Kong Q, Liu C, Zhang Y, He Y, Zhang R, Wang Y, et al. Nucleic acid aptamer-based electrochemical sensor for the detection of serum P-tau231 and the instant screening test of Alzheimer\u2019s disease. Microchim Acta. 2024. https:\/\/doi.org\/10.1007\/s00604-024-06395-0.","DOI":"10.1007\/s00604-024-06395-0"},{"key":"1932_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2024.125736","volume":"271","author":"L Oldak","year":"2024","unstructured":"Oldak L, Zielinska Z, Socha K, Bogdan S, Gorodkiewicz E, Elsevier BV. Phospho-Tau 181 quantification method for Alzheimer\u2019s disease based on an array 2D biosensor combined with surface plasmon resonance imaging. Talanta. 2024;271:125736. https:\/\/doi.org\/10.1016\/j.talanta.2024.125736.","journal-title":"Talanta"},{"key":"1932_CR21","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1039\/d4bm00654b","volume":"12","author":"MM Rahman","year":"2024","unstructured":"Rahman MM, Sarkar B, Rahman MT, Jin GJ, Uddin MJ, Bhuiyan NH, et al. Development of a highly sensitive CNT-metal graphene hybrid nano-IDA electrochemical biosensor for the diagnosis of Alzheimer\u2019s disease. Biomater Sci. 2024;12:5203\u201314. https:\/\/doi.org\/10.1039\/d4bm00654b.","journal-title":"Biomater Sci"},{"key":"1932_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202200138","author":"A Cario","year":"2023","unstructured":"Cario A, Berger CL, Wiley. Tau, microtubule dynamics, and axonal transport: new paradigms for neurodegenerative disease. Bioessays. 2023. https:\/\/doi.org\/10.1002\/bies.202200138.","journal-title":"Bioessays"},{"key":"1932_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1101\/gad.352551.124","volume":"39","author":"M Van Alstyne","year":"2025","unstructured":"Van Alstyne M, Pratt J, Parker R. Diverse influences on tau aggregation and implications for disease progression. Genes Dev. 2025;39:555\u201381. https:\/\/doi.org\/10.1101\/gad.352551.124.","journal-title":"Genes Dev"},{"key":"1932_CR24","doi-asserted-by":"publisher","unstructured":"Buchholz S, Kabbani MAA, Bell\u2010Simons M, Kluge L, Cagmak C, Klimek J, et al. The tau isoform 1N4R confers vulnerability of MAPT knockout human iPSC\u2010derived neurons to amyloid beta and phosphorylated tau\u2010induced neuronal dysfunction. Alzheimers Dement. 2025. https:\/\/doi.org\/10.1002\/alz.14403.","DOI":"10.1002\/alz.14403"},{"key":"1932_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.643115","author":"S Bachmann","year":"2021","unstructured":"Bachmann S, Bell M, Klimek J, Zempel H, Front Media SA. Differential effects of the six human TAU isoforms: somatic retention of 2N-TAU and increased microtubule number induced by 4R-TAU. Front Neurosci. 2021. https:\/\/doi.org\/10.3389\/fnins.2021.643115.","journal-title":"Front Neurosci"},{"key":"1932_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-024-01748-5","author":"N Basheer","year":"2024","unstructured":"Basheer N, Buee L, Brion J-P, Smolek T, Muhammadi MK, Hritz J, et al. Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer\u2019s disease: a systematic review of tau propagation models. Acta Neuropathol Commun. 2024. https:\/\/doi.org\/10.1186\/s40478-024-01748-5.","journal-title":"Acta Neuropathol Commun"},{"key":"1932_CR27","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.3390\/molecules29122812","volume":"29","author":"J Yang","year":"2024","unstructured":"Yang J, Zhi W, Wang L, MDPI AG. Role of tau protein in neurodegenerative diseases and development of its targeted drugs: a literature review. Molecules. 2024;29:2812. https:\/\/doi.org\/10.3390\/molecules29122812.","journal-title":"Molecules"},{"key":"1932_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102639","volume":"104","author":"S Singh","year":"2025","unstructured":"Singh S, Khan S, Shahid M, Sardar M, Hassan MdI, Islam A. Targeting tau in Alzheimer\u2019s and beyond: insights into pathology and therapeutic strategies. Ageing Res Rev. 2025;104:102639. https:\/\/doi.org\/10.1016\/j.arr.2024.102639.","journal-title":"Ageing Res Rev"},{"key":"1932_CR29","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1038\/s41591-022-02075-9","volume":"28","author":"K Horie","year":"2022","unstructured":"Horie K, Barth\u00e9lemy NR, Spina S, VandeVrede L, He Y, Paterson RW, et al. CSF tau microtubule-binding region identifies pathological changes in primary tauopathies. Nat Med. 2022;28:2547\u201354. https:\/\/doi.org\/10.1038\/s41591-022-02075-9.","journal-title":"Nat Med"},{"key":"1932_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00586-0","author":"J Gobom","year":"2022","unstructured":"Gobom J, Benedet AL, Mattsson-Carlgren N, Montoliu-Gaya L, Schultz N, Ashton NJ, et al. Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer\u2019s disease continuum. Mol Neurodegener. 2022. https:\/\/doi.org\/10.1186\/s13024-022-00586-0.","journal-title":"Mol Neurodegener"},{"key":"1932_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang X, Oxford University Press (OUP). Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell. 2025;16:83\u2013120. https:\/\/doi.org\/10.1093\/procel\/pwae026.","journal-title":"Protein Cell"},{"key":"1932_CR32","doi-asserted-by":"publisher","unstructured":"Kunach P, Vaquer-Alicea J, Smith MS, Hopewell R, Monistrol J, Moquin L, et al. Cryo-EM structure of Alzheimer\u2019s disease tau filaments with PET ligand MK-6240. Cold Spring Harbor Laboratory; 2023. https:\/\/doi.org\/10.1101\/2023.09.22.558671","DOI":"10.1101\/2023.09.22.558671"},{"key":"1932_CR33","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1002\/alz.13784","volume":"20","author":"S Buchholz","year":"2024","unstructured":"Buchholz S, Zempel H. The six brain-specific TAU isoforms and their role in Alzheimer\u2019s disease and related neurodegenerative dementia syndromes. Alzheimer\u2019s & Dementia. 2024;20:3606\u201328. https:\/\/doi.org\/10.1002\/alz.13784.","journal-title":"Alzheimer's & Dementia"},{"key":"1932_CR34","doi-asserted-by":"publisher","first-page":"15383","DOI":"10.3390\/ijms232315383","volume":"23","author":"A Corsi","year":"2022","unstructured":"Corsi A, Bombieri C, Valenti MT, Romanelli MG. Tau isoforms: gaining insight into MAPT alternative splicing. IJMS. 2022;23:15383. https:\/\/doi.org\/10.3390\/ijms232315383.","journal-title":"IJMS"},{"key":"1932_CR35","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1021\/acschemneuro.2c00188","volume":"13","author":"R Cuadros","year":"2022","unstructured":"Cuadros R, P\u00e9rez M, Ruiz-Gabarre D, Hern\u00e1ndez F, Garc\u00eda-Escudero V, Avila J. Specific peptide from the novel W-Tau isoform inhibits Tau and amyloid \u03b2 peptide aggregation in vitro. ACS Chem Neurosci. 2022;13:1974\u20138. https:\/\/doi.org\/10.1021\/acschemneuro.2c00188.","journal-title":"ACS Chem Neurosci"},{"key":"1932_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104939","volume":"141","author":"SA Koren","year":"2020","unstructured":"Koren SA, Galvis-Escobar S, Abisambra JF. Tau-mediated dysregulation of RNA: evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies. Neurobiol Dis. 2020;141:104939. https:\/\/doi.org\/10.1016\/j.nbd.2020.104939.","journal-title":"Neurobiol Dis"},{"key":"1932_CR37","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","volume":"185","author":"TE Tracy","year":"2022","unstructured":"Tracy TE, Madero-P\u00e9rez J, Swaney DL, Chang TS, Moritz M, Konrad C, et al. Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell. 2022;185:712-728.e14. https:\/\/doi.org\/10.1016\/j.cell.2021.12.041.","journal-title":"Cell"},{"key":"1932_CR38","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrd.2017.155","volume":"16","author":"C Li","year":"2017","unstructured":"Li C, G\u00f6tz J, Springer Science and Business Media LLC. Tau-based therapies in neurodegeneration: opportunities and challenges. Nat Rev Drug Discov. 2017;16:863\u201383. https:\/\/doi.org\/10.1038\/nrd.2017.155.","journal-title":"Nat Rev Drug Discov"},{"key":"1932_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ, et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature. 2017;547:185\u201390. https:\/\/doi.org\/10.1038\/nature23002.","journal-title":"Nature"},{"key":"1932_CR40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1021\/acschemneuro.2c00611","volume":"14","author":"VH Man","year":"2023","unstructured":"Man VH, He X, Gao J, Wang J, American Chemical Society (ACS). Phosphorylation of tau R2 repeat destabilizes its binding to microtubules: a molecular dynamics simulation study. ACS Chem Neurosci. 2023;14:458\u201367. https:\/\/doi.org\/10.1021\/acschemneuro.2c00611.","journal-title":"ACS Chem Neurosci"},{"key":"1932_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ibra.12176","volume":"10","author":"X Li","year":"2024","unstructured":"Li X, Ba Z, Huang J, Chen J, Jiang J, Huang N, et al. Comprehensive review on Alzheimer\u2019s disease: from the posttranslational modifications of tau to corresponding treatments. Ibrain. 2024;10:427\u201338. https:\/\/doi.org\/10.1002\/ibra.12176.","journal-title":"Ibrain"},{"key":"1932_CR42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.neuron.2018.01.022","volume":"97","author":"J McInnes","year":"2018","unstructured":"McInnes J, Wierda K, Snellinx A, Bounti L, Wang Y-C, Stancu I-C, et al. Synaptogyrin-3 mediates presynaptic dysfunction induced by tau. Neuron. 2018;97:823-835.e8. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.022.","journal-title":"Neuron"},{"key":"1932_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43130-4","author":"SF Longfield","year":"2023","unstructured":"Longfield SF, Mollazade M, Wallis TP, Gormal RS, Joensuu M, Wark JR, et al. Tau forms synaptic nano-biomolecular condensates controlling the dynamic clustering of recycling synaptic vesicles. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-43130-4.","journal-title":"Nat Commun"},{"key":"1932_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42295-2","author":"Z Shen","year":"2023","unstructured":"Shen Z, Sun D, Savastano A, Varga SJ, Cima-Omori M-S, Becker S, et al. Multivalent Tau\/PSD-95 interactions arrest in vitro condensates and clusters mimicking the postsynaptic density. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-42295-2.","journal-title":"Nat Commun"},{"key":"1932_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1043384","author":"L Huang","year":"2022","unstructured":"Huang L, Zhang Z. CSP\u03b1 in neurodegenerative diseases. Front Aging Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnagi.2022.1043384.","journal-title":"Front Aging Neurosci"},{"key":"1932_CR46","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3390\/cells9092135","volume":"9","author":"N Esteras","year":"2020","unstructured":"Esteras N, Abramov AY, MDPI AG. Mitochondrial calcium deregulation in the mechanism of beta-amyloid and tau pathology. Cells. 2020;9:2135. https:\/\/doi.org\/10.3390\/cells9092135.","journal-title":"Cells"},{"key":"1932_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.01.007","author":"M Wang","year":"2025","unstructured":"Wang M, Zhang H, Liang J, Huang J, Wu T, Chen N. Calcium signaling hypothesis: a non-negligible pathogenesis in Alzheimer\u2019s disease. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.01.007.","journal-title":"J Adv Res"},{"key":"1932_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.852368","author":"AJ Trease","year":"2022","unstructured":"Trease AJ, George JW, Roland NJ, Lichter EZ, Emanuel K, Totusek S, et al. Hyperphosphorylated human tau accumulates at the synapse, localizing on synaptic mitochondrial outer membranes and disrupting respiration in a mouse model of tauopathy. Front Mol Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnmol.2022.852368.","journal-title":"Front Mol Neurosci"},{"key":"1932_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01552-7","author":"W Wang","year":"2023","unstructured":"Wang W, Zhao F, Lu Y, Siedlak SL, Fujioka H, Feng H, et al. Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in Alzheimer\u2019s disease brain. Acta Neuropathol Commun. 2023. https:\/\/doi.org\/10.1186\/s40478-023-01552-7.","journal-title":"Acta Neuropathol Commun"},{"key":"1932_CR50","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/jnc.15144","volume":"156","author":"S De La-Rocque","year":"2021","unstructured":"De La-Rocque S, Moretto E, Butnaru I, Schiavo G, Wiley. Knockin\u2019 on heaven\u2019s door: Molecular mechanisms of neuronal tau uptake. J Neurochem. 2021;156:563\u201388. https:\/\/doi.org\/10.1111\/jnc.15144.","journal-title":"J Neurochem"},{"key":"1932_CR51","doi-asserted-by":"publisher","DOI":"10.7554\/elife.73542","author":"T Hori","year":"2022","unstructured":"Hori T, Eguchi K, Wang H-Y, Miyasaka T, Guillaud L, Taoufiq Z, et al. Microtubule assembly by tau impairs endocytosis and neurotransmission via dynamin sequestration in Alzheimer\u2019s disease synapse model. eLife. 2022. https:\/\/doi.org\/10.7554\/elife.73542.","journal-title":"eLife"},{"key":"1932_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.671779","author":"X Yin","year":"2021","unstructured":"Yin X, Zhao C, Qiu Y, Zhou Z, Bao J, Qian W. Dendritic\/post-synaptic Tau and early pathology of Alzheimer\u2019s disease. Front Mol Neurosci. 2021. https:\/\/doi.org\/10.3389\/fnmol.2021.671779.","journal-title":"Front Mol Neurosci"},{"key":"1932_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrn3012","volume":"12","author":"G Di Paolo","year":"2011","unstructured":"Di Paolo G, Kim T-W. Linking lipids to Alzheimer\u2019s disease: cholesterol and beyond. Nat Rev Neurosci. 2011;12:284\u201396. https:\/\/doi.org\/10.1038\/nrn3012.","journal-title":"Nat Rev Neurosci"},{"key":"1932_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/jad-2009-0933","volume":"16","author":"P Hernandez","year":"2009","unstructured":"Hernandez P, Lee G, Sjoberg M, Maccioni RB. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide A\u03b225\u201335: involvement of lipid rafts. J Alzheimers Dis. 2009;16:149\u201356. https:\/\/doi.org\/10.3233\/jad-2009-0933.","journal-title":"J Alzheimers Dis"},{"key":"1932_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03060-4","author":"D Ole\u0161ov\u00e1","year":"2024","unstructured":"Ole\u0161ov\u00e1 D, Dobe\u0161ov\u00e1 D, Majerov\u00e1 P, Brumarov\u00e1 R, Kvasni\u010dka A, Kou\u0159il \u0160, et al. Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies. J Neuroinflammation. 2024. https:\/\/doi.org\/10.1186\/s12974-024-03060-4.","journal-title":"J Neuroinflammation"},{"key":"1932_CR56","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1042\/bj3010871","volume":"301","author":"M Goedert","year":"1994","unstructured":"Goedert M, Jakes R, Crowther RA, Cohen P, Vanmechelen E, Vandermeeren M, et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer\u2019s disease: identification of phosphorylation sites in tau protein. Biochem J. 1994;301:871\u20137. https:\/\/doi.org\/10.1042\/bj3010871.","journal-title":"Biochem J"},{"key":"1932_CR57","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1212\/wnl.59.4.627","volume":"59","author":"K Buerger","year":"2002","unstructured":"Buerger K, Teipel SJ, Zinkowski R, Blennow K, Arai H, Engel R, et al. CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurol Ovid Technol (Wolters Kluwer Health). 2002;59:627\u20139. https:\/\/doi.org\/10.1212\/wnl.59.4.627.","journal-title":"Neurol Ovid Technol (Wolters Kluwer Health)"},{"key":"1932_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0206-8","author":"H Tatebe","year":"2017","unstructured":"Tatebe H, Kasai T, Ohmichi T, Kishi Y, Kakeya T, Waragai M, et al. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer\u2019s disease and down syndrome. Mol Neurodegener. 2017. https:\/\/doi.org\/10.1186\/s13024-017-0206-8.","journal-title":"Mol Neurodegener"},{"key":"1932_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103836","volume":"76","author":"NJ Ashton","year":"2022","unstructured":"Ashton NJ, Benedet AL, Pascoal TA, Karikari TK, Lantero-Rodriguez J, Brum WS, et al. Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer\u2019s disease. EBioMedicine. 2022;76:103836. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103836.","journal-title":"EBioMedicine"},{"key":"1932_CR60","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, et al. Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology. Acta Neuropathol. 2021;141:709\u201324. https:\/\/doi.org\/10.1007\/s00401-021-02275-6. Springer Science and Business Media LLC.","journal-title":"Acta Neuropathol"},{"key":"1932_CR61","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/alz.12751","volume":"19","author":"S Palmqvist","year":"2023","unstructured":"Palmqvist S, Stomrud E, Cullen N, Janelidze S, Manuilova E, Jethwa A, et al. An accurate fully automated panel of plasma biomarkers for Alzheimer\u2019s disease. Alzheimers Dement. 2023;19:1204\u201315. https:\/\/doi.org\/10.1002\/alz.12751.","journal-title":"Alzheimers Dement"},{"key":"1932_CR62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s004010100423","volume":"103","author":"JC Augustinack","year":"2002","unstructured":"Augustinack JC, Schneider A, Mandelkow E-M, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer\u2019s disease. Acta Neuropathol. 2002;103:26\u201335. https:\/\/doi.org\/10.1007\/s004010100423.","journal-title":"Acta Neuropathol"},{"key":"1932_CR63","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12031-008-9044-z","volume":"35","author":"C Conejero-Goldberg","year":"2008","unstructured":"Conejero-Goldberg C, Townsend K, Davies P. Effects of cell cycle inhibitors on tau phosphorylation in N2aTau3R cells. J Mol Neurosci. 2008;35:143\u201350. https:\/\/doi.org\/10.1007\/s12031-008-9044-z. Springer Science and Business Media LLC.","journal-title":"J Mol Neurosci"},{"issue":"4","key":"1932_CR64","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/prot.24988","volume":"84","author":"TJ Malia","year":"2016","unstructured":"Malia TJ, Teplyakov A, Ernst R, Wu S, Lacy ER, Liu X, et al. <article-title update=\"added\">Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti\u2010tau antibody AT8. Proteins Struct Funct Bioinform. 2016;84(4):427\u201334. https:\/\/doi.org\/10.1002\/prot.24988.","journal-title":"Proteins Struct Funct Bioinform"},{"key":"1932_CR65","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/jnc.14830","volume":"152","author":"D Li","year":"2020","unstructured":"Li D, Cho YK. High specificity of widely used phospho-tau antibodies validated using a quantitative whole-cell based assay. J Neurochem. 2020;152:122\u201335. https:\/\/doi.org\/10.1111\/jnc.14830.","journal-title":"J Neurochem"},{"key":"1932_CR66","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00702-003-0065-z","volume":"111","author":"H Hampel","year":"2004","unstructured":"Hampel H, Mitchell A, Blennow K, Frank RA, Brettschneider S, Weller L, et al. Core biological marker candidates of Alzheimer?s disease\u202f? perspectives for diagnosis, prediction of outcome and reflection of biological activity. J Neural Transm. 2004;111:247\u201372. https:\/\/doi.org\/10.1007\/s00702-003-0065-z.","journal-title":"J Neural Transm"},{"key":"1932_CR67","doi-asserted-by":"publisher","unstructured":"Ferreira D, Perestelo-P\u00c3\u00a9rez L, Westman E, Wahlund L-O, Sarr\u00c3\u00ada A, Serrano-Aguilar P. Meta-review of CSF core biomarkers in Alzheimer\u00e2\u20acTMs disease: The State-of-the-Art after the new revised diagnostic criteria. Front Aging Neurosci. Frontiers Media SA; 2014;6. https:\/\/doi.org\/10.3389\/fnagi.2014.00047","DOI":"10.3389\/fnagi.2014.00047"},{"key":"1932_CR68","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/abt\/tbab004","volume":"4","author":"M Arbaciauskaite","year":"2021","unstructured":"Arbaciauskaite M, Lei Y, Cho YK. High-specificity antibodies and detection methods for quantifying phosphorylated tau from clinical samples. Antibody Therapeutics. 2021;4:34\u201344. https:\/\/doi.org\/10.1093\/abt\/tbab004.","journal-title":"Antibody Therapeutics"},{"key":"1932_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14458","author":"M Khalafi","year":"2025","unstructured":"Khalafi M, Dartora WJ, McIntire LBJ, Butler TA, Wartchow KM, Hojjati SH, et al. Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer\u2019s disease pathology among cognitively impaired and unimpaired: a systematic review and meta\u2010analysis. Alzheimers Dement. 2025. https:\/\/doi.org\/10.1002\/alz.14458.","journal-title":"Alzheimers Dement"},{"key":"1932_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00439-4","author":"K Tagai","year":"2024","unstructured":"Tagai K, Tatebe H, Matsuura S, Hong Z, Kokubo N, Matsuoka K, et al. A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer\u2019s disease. Transl Neurodegener. 2024. https:\/\/doi.org\/10.1186\/s40035-024-00439-4.","journal-title":"Transl Neurodegener"},{"key":"1932_CR71","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1002\/alz.13119","volume":"19","author":"J Lantero-Rodriguez","year":"2023","unstructured":"Lantero-Rodriguez J, Tissot C, Snellman A, Servaes S, Benedet AL, Rahmouni N, et al. Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burden. Alzheimers Dement. 2023;19:5343\u201354. https:\/\/doi.org\/10.1002\/alz.13119.","journal-title":"Alzheimers Dement"},{"key":"1932_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-00967-w","volume":"8","author":"Y Xia","year":"2020","unstructured":"Xia Y, Prokop S, Gorion K-MM, Kim JD, Sorrentino ZA, Bell BM, et al. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer\u2019s disease and other tauopathies. Acta Neuropathol Commun. 2020;8:88. https:\/\/doi.org\/10.1186\/s40478-020-00967-w.","journal-title":"Acta Neuropathol Commun"},{"key":"1932_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00460-5","author":"Y Xia","year":"2021","unstructured":"Xia Y, Prokop S, Giasson BI. \u201cDon\u2019t Phos Over Tau\u201d: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer\u2019s disease and other tauopathies. Mol Neurodegener. 2021. https:\/\/doi.org\/10.1186\/s13024-021-00460-5.","journal-title":"Mol Neurodegener"},{"key":"1932_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/alz.082771","author":"J Zhou","year":"2023","unstructured":"Zhou J, Rawal S, Yagi T, Wildsmith KR, Takahashi E, Horie K, et al. E2814: an anti\u2010tau therapy engages its CNS target and affects the downstream tangle\u2010specific biomarker MTBR\u2010tau243 in Dominantly Inherited Alzheimer\u2019s Disease. Alzheimers Dement. 2023. https:\/\/doi.org\/10.1002\/alz.082771.","journal-title":"Alzheimers Dement"},{"key":"1932_CR75","doi-asserted-by":"publisher","first-page":"1150510","DOI":"10.3389\/fnagi.2023.1150510","volume":"15","author":"B Zhang","year":"2023","unstructured":"Zhang B, Zhang C, Wang Y, Chen L, Qiao Y, Wang Y, et al. Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer\u2019s disease. Front Aging Neurosci. 2023;15:1150510. https:\/\/doi.org\/10.3389\/fnagi.2023.1150510.","journal-title":"Front Aging Neurosci"},{"key":"1932_CR76","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1093\/brain\/awaa286","volume":"143","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren N, Janelidze S, Palmqvist S, Cullen N, Svenningsson AL, Strandberg O, et al. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer\u2019s disease. Brain. 2020;143:3234\u201341. https:\/\/doi.org\/10.1093\/brain\/awaa286.","journal-title":"Brain"},{"key":"1932_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14397","volume":"21","author":"CE Teunissen","year":"2025","unstructured":"Teunissen CE, Kolster R, Triana-Baltzer G, Janelidze S, Zetterberg H, Kolb HC. Plasma p-tau immunoassays in clinical research for Alzheimer\u2019s disease. Alzheimers Dement. 2025;21:e14397. https:\/\/doi.org\/10.1002\/alz.14397.","journal-title":"Alzheimers Dement"},{"key":"1932_CR78","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/acn3.51553","volume":"9","author":"S De Meyer","year":"2022","unstructured":"De Meyer S, Vanbrabant J, Schaeverbeke JM, Reinartz M, Luckett ES, Dupont P, et al. Phospho-specific plasma p-tau181 assay detects clinical as well as asymptomatic Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2022;9:734\u201346. https:\/\/doi.org\/10.1002\/acn3.51553.","journal-title":"Ann Clin Transl Neurol"},{"key":"1932_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.695696","volume":"12","author":"Y-L Wang","year":"2021","unstructured":"Wang Y-L, Chen J, Du Z-L, Weng H, Zhang Y, Li R, et al. Plasma p-tau181 level predicts neurodegeneration and progression to Alzheimer\u2019s dementia: a longitudinal study. Front Neurol. 2021;12:695696. https:\/\/doi.org\/10.3389\/fneur.2021.695696.","journal-title":"Front Neurol"},{"key":"1932_CR80","doi-asserted-by":"publisher","unstructured":"Ashton NJ, Keshavan A, Brum WS, Andreasson U, Arslan B, Droescher M, et al. The Alzheimers Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study. Neurology; 2024 https:\/\/doi.org\/10.1101\/2024.08.22.24312244","DOI":"10.1101\/2024.08.22.24312244"},{"key":"1932_CR81","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13195-024-01469-w","volume":"16","author":"Y Niimi","year":"2024","unstructured":"Niimi Y, Janelidze S, Sato K, Tomita N, Tsukamoto T, Kato T, et al. Combining plasma A\u03b2 and p-tau217 improves detection of brain amyloid in non-demented elderly. Alz Res Ther. 2024;16:115. https:\/\/doi.org\/10.1186\/s13195-024-01469-w.","journal-title":"Alz Res Ther"},{"key":"1932_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01826-3","volume":"17","author":"H Kang","year":"2025","unstructured":"Kang H, Yoo H, Lee J, Yoon S, Zetterberg H, Blennow K, et al. Plasma phosphorylated tau 217 and amyloid-\u03b2 42\/40 for amyloid risk in subgroups. Alzheimers Res Ther. 2025;17:184. https:\/\/doi.org\/10.1186\/s13195-025-01826-3.","journal-title":"Alzheimers Res Ther"},{"key":"1932_CR83","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/clinchem\/hvac149","volume":"68","author":"Z Xiao","year":"2022","unstructured":"Xiao Z, Wu W, Ma X, Liang X, Lu J, Zheng L, et al. Plasma A\u03b242\/A\u03b240 and p-tau181 predict long-term clinical progression in a cohort with amnestic mild cognitive impairment. Clin Chem. 2022;68:1552\u201363. https:\/\/doi.org\/10.1093\/clinchem\/hvac149.","journal-title":"Clin Chem"},{"key":"1932_CR84","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/s41591-025-03605-x","volume":"31","author":"G Grande","year":"2025","unstructured":"Grande G, Valletta M, Rizzuto D, Xia X, Qiu C, Orsini N, et al. Blood-based biomarkers of Alzheimer\u2019s disease and incident dementia in the community. Nat Med. 2025;31:2027\u201335. https:\/\/doi.org\/10.1038\/s41591-025-03605-x.","journal-title":"Nat Med"},{"key":"1932_CR85","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/alz.12724","volume":"19","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee P, Pedrini S, Doecke JD, Thota R, Villemagne VL, Dor\u00e9 V, et al. Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: a cross-sectional and longitudinal study in the AIBL cohort. Alzheimers Dement. 2023;19:1117\u201334. https:\/\/doi.org\/10.1002\/alz.12724.","journal-title":"Alzheimers Dement"},{"key":"1932_CR86","doi-asserted-by":"publisher","first-page":"e70044","DOI":"10.1002\/alz.70044","volume":"21","author":"J Xu","year":"2025","unstructured":"Xu J, Su Y, Sha Y, Fu J, Yan T, Xu F, et al. Circulating proteomic biomarkers for cerebral amyloid angiopathy screening and risk stratification. Alzheimers Dement. 2025;21:e70044. https:\/\/doi.org\/10.1002\/alz.70044.","journal-title":"Alzheimers Dement"},{"key":"1932_CR87","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00604-024-06395-0","volume":"191","author":"Q Kong","year":"2024","unstructured":"Kong Q, Liu C, Zhang Y, He Y, Zhang R, Wang Y, et al. Nucleic acid aptamer-based electrochemical sensor for the detection of serum P-tau231 and the instant screening test of Alzheimer\u2019s disease. Microchim Acta. 2024;191:328. https:\/\/doi.org\/10.1007\/s00604-024-06395-0.","journal-title":"Microchim Acta"},{"key":"1932_CR88","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/bios14060279","volume":"14","author":"M Yang","year":"2024","unstructured":"Yang M, Chen Y, Sun H, Li D, Li Y. A simple sandwich electrochemical immunosensor for rapid detection of the Alzheimer\u2019s disease biomarker Tau protein. Biosensors. 2024;14:279. https:\/\/doi.org\/10.3390\/bios14060279.","journal-title":"Biosensors"},{"key":"1932_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2024.116085","volume":"250","author":"S Kim","year":"2024","unstructured":"Kim S, Ma X, Jeon MJ, Song S, Lee JS, Lee JU, et al. Distinct plasma phosphorylated-tau proteins profiling for the differential diagnosis of mild cognitive impairment and Alzheimer\u2019s disease by plasmonic asymmetric nanobridge-based biosensor. Biosens Bioelectron. 2024;250:116085. https:\/\/doi.org\/10.1016\/j.bios.2024.116085.","journal-title":"Biosens Bioelectron"},{"key":"1932_CR90","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1021\/acssensors.4c02037","volume":"9","author":"YJ Choi","year":"2024","unstructured":"Choi YJ, Haddadnezhad M, Baek SJ, Lee C-N, Park S, Sim SJ. Plasmonic nanogap-enhanced tunable three-dimensional nanoframes in application to clinical diagnosis of Alzheimer\u2019s disease. ACS Sens. 2024;9:5587\u201395. https:\/\/doi.org\/10.1021\/acssensors.4c02037.","journal-title":"ACS Sens"},{"key":"1932_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbsr.2024.100717","volume":"46","author":"P Ramirez-Priego","year":"2024","unstructured":"Ramirez-Priego P, Mauriz E, Giarola JF, Lechuga LM. Overcoming challenges in plasmonic biosensors deployment for clinical and biomedical applications: a systematic review and meta-analysis. Sens Biosens Res. 2024;46:100717. https:\/\/doi.org\/10.1016\/j.sbsr.2024.100717.","journal-title":"Sens Biosens Res"},{"key":"1932_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12617","volume":"16","author":"BM Asken","year":"2024","unstructured":"Asken BM, DeSimone JC, Wang W, McFarland KN, Arias F, Levy S, et al. Plasma p-tau217 concordance with amyloid PET among ethnically diverse older adults. Alzheimers Dement Diagn Assess Dis Monit. 2024;16:e12617. https:\/\/doi.org\/10.1002\/dad2.12617.","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"1932_CR93","doi-asserted-by":"publisher","first-page":"100717","DOI":"10.1016\/j.lanhl.2025.100717","volume":"6","author":"MA Heiskanen","year":"2025","unstructured":"Heiskanen MA, Mykk\u00e4nen J, Pahkala K, Juonala M, K\u00e4h\u00f6nen M, Lehtim\u00e4ki T, et al. Factors related to blood-based biomarkers for neurodegenerative diseases and their intergenerational associations in the Young Finns Study: a cohort study. Lancet Healthy Longev. 2025;6:100717. https:\/\/doi.org\/10.1016\/j.lanhl.2025.100717.","journal-title":"Lancet Healthy Longev"},{"key":"1932_CR94","doi-asserted-by":"publisher","first-page":"105741","DOI":"10.1016\/j.ebiom.2025.105741","volume":"116","author":"A Gonz\u00e1lez-Escalante","year":"2025","unstructured":"Gonz\u00e1lez-Escalante A, Mil\u00e0-Alom\u00e0 M, Brum WS, Ashton NJ, Ortiz-Romero P, Shekari M, et al. A plasma biomarker panel for detecting early amyloid-\u03b2 accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer\u2019s disease. EBioMedicine. 2025;116:105741. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105741.","journal-title":"EBioMedicine"},{"key":"1932_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105345","volume":"108","author":"A Cano","year":"2024","unstructured":"Cano A, Capdevila M, Puerta R, Arranz J, Montrreal L, De Rojas I, et al. Clinical value of plasma pTau181 to predict Alzheimer\u2019s disease pathology in a large real-world cohort of a memory clinic. EBioMedicine. 2024;108:105345. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105345.","journal-title":"EBioMedicine"},{"key":"1932_CR96","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1038\/s41598-025-90232-8","volume":"15","author":"HS Kwon","year":"2025","unstructured":"Kwon HS, Hwang M, Koh S-H, Choi SH, Lee J-H, Kim H-J, et al. Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients. Sci Rep. 2025;15:7791. https:\/\/doi.org\/10.1038\/s41598-025-90232-8.","journal-title":"Sci Rep"},{"key":"1932_CR97","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awac333","volume":"146","author":"S Janelidze","year":"2023","unstructured":"Janelidze S, Bali D, Ashton NJ, Barth\u00e9lemy NR, Vanbrabant J, Stoops E, et al. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease. Brain. 2023;146:1592\u2013601. https:\/\/doi.org\/10.1093\/brain\/awac333.","journal-title":"Brain"},{"key":"1932_CR98","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.14283\/jpad.2024.58","volume":"11","author":"GM Giuffr\u00e8","year":"2024","unstructured":"Giuffr\u00e8 GM, Quaranta D, Vita MG, Costantini EM, Citro S, Carrozza C, et al. Performance of fully-automated high-throughput plasma biomarker assays for Alzheimer\u2019s disease in amnestic mild cognitive impairment subjects. J Prev Alzheimers Dis. 2024;11:1073\u20138. https:\/\/doi.org\/10.14283\/jpad.2024.58.","journal-title":"J Prev Alzheimers Dis"},{"key":"1932_CR99","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1038\/s43587-025-00951-w","volume":"5","author":"L Montoliu-Gaya","year":"2025","unstructured":"Montoliu-Gaya L, Salvad\u00f3 G, Therriault J, Nilsson J, Janelidze S, Weiner S, et al. Plasma tau biomarkers for biological staging of Alzheimer\u2019s disease. Nat Aging. 2025;5:2297\u2013308. https:\/\/doi.org\/10.1038\/s43587-025-00951-w.","journal-title":"Nat Aging"},{"key":"1932_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14609","volume":"21","author":"F Anastasi","year":"2025","unstructured":"Anastasi F, Fern\u00e1ndez-Lebrero A, Ashton NJ, Ortiz-Romero P, Torres-Torronteras J, Gonz\u00e1lez-Escalante A, et al. A head-to-head comparison of plasma biomarkers to detect Alzheimer\u2019s disease in a memory clinic. Alzheimers Dement. 2025;21:e14609. https:\/\/doi.org\/10.1002\/alz.14609.","journal-title":"Alzheimers Dement"},{"key":"1932_CR101","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12465","volume":"15","author":"C Giangrande","year":"2023","unstructured":"Giangrande C, Delatour V, Andreasson U, Blennow K, Gobom J, Zetterberg H. Harmonization and standardization of biofluid-based biomarker measurements for AT(N) classification in Alzheimer\u2019s disease. Alzheimers Dement Diagn Assess Dis Monit. 2023;15:e12465. https:\/\/doi.org\/10.1002\/dad2.12465.","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"1932_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01513-9","volume":"16","author":"J Arranz","year":"2024","unstructured":"Arranz J, Zhu N, Rubio-Guerra S, Rodr\u00edguez-Baz \u00cd, Ferrer R, Carmona-Iragui M, et al. Diagnostic performance of plasma pTau217, pTau181, A\u03b21-42 and A\u03b21-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Alzheimers Res Ther. 2024;16:139. https:\/\/doi.org\/10.1186\/s13195-024-01513-9.","journal-title":"Alzheimers Res Ther"},{"key":"1932_CR103","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3233\/ADR-230029","volume":"7","author":"MV Pais","year":"2023","unstructured":"Pais MV, Forlenza OV, Diniz BS. Plasma biomarkers of Alzheimer\u2019s disease: a review of available assays, recent developments, and implications for clinical practice. J Alzheimers Dis Rep. 2023;7:355\u201380. https:\/\/doi.org\/10.3233\/ADR-230029.","journal-title":"J Alzheimers Dis Rep"},{"key":"1932_CR104","doi-asserted-by":"publisher","unstructured":"Wang G, Li Y, Xiong C, Cao Y, Schindler SE, McDade E, et al. The CentiMarker Project: standardizing quantitative Alzheimer\u2019s disease fluid biomarkers for biologic interpretation. Neurology; 2024 https:\/\/doi.org\/10.1101\/2024.07.25.24311002","DOI":"10.1101\/2024.07.25.24311002"},{"key":"1932_CR105","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1021\/acsphyschemau.2c00061","volume":"3","author":"S Dey","year":"2023","unstructured":"Dey S, Dolci M, Zijlstra P. Single-molecule optical biosensing: recent advances and future challenges. ACS Phys Chem Au. 2023;3:143\u201356. https:\/\/doi.org\/10.1021\/acsphyschemau.2c00061.","journal-title":"ACS Phys Chem Au"},{"issue":"4","key":"1932_CR106","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/nep3.58","volume":"2","author":"Y Liu","year":"2024","unstructured":"Liu Y, Guo Y, Yu J. Blood-based biomarkers of Alzheimer\u2019s disease: standardization and comprehensiveness. Neuroprotection. 2024;2(4):246\u201354. https:\/\/doi.org\/10.1002\/nep3.58.","journal-title":"Neuroprotection"},{"key":"1932_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2025.120278","volume":"572","author":"S Matlyuba Jakhonkulovna","year":"2025","unstructured":"Matlyuba Jakhonkulovna S, Bahodirova Kamolovna G, Zokirov M, Umida Tajimuratovna B, Yumashev A, Shichiyakh R, et al. Electrochemical biosensors for early detection of Alzheimer\u2019s disease. Clin Chim Acta. 2025;572:120278. https:\/\/doi.org\/10.1016\/j.cca.2025.120278.","journal-title":"Clin Chim Acta"},{"key":"1932_CR108","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1515\/cclm-2023-0571","volume":"61","author":"R Greaves","year":"2023","unstructured":"Greaves R, Kricka L, Gruson D, Ferrari M, Martin H, Loh TP, et al. Toolkit for emerging technologies in laboratory medicine. Clinical Chemistry and Laboratory Medicine (CCLM). 2023;61:2102\u201314. https:\/\/doi.org\/10.1515\/cclm-2023-0571.","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"key":"1932_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00711-1","volume":"19","author":"X Zeng","year":"2024","unstructured":"Zeng X, Chen Y, Sehrawat A, Lee J, Lafferty TK, Kofler J, et al. Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting. Mol Neurodegener. 2024;19:40. https:\/\/doi.org\/10.1186\/s13024-024-00711-1.","journal-title":"Mol Neurodegener"},{"key":"1932_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01630-5","author":"AL Wojda\u0142a","year":"2024","unstructured":"Wojda\u0142a AL, Vanbrabant J, Bayoumy S, Antwi-Berko D, Bastard NL, Van Der Flier WM, et al. Analytical and clinical performance of eight Simoa\u00ae and Lumipulse\u00ae assays for automated measurement of plasma p-tau181 and p-tau217. Alz Res Ther. 2024. https:\/\/doi.org\/10.1186\/s13195-024-01630-5.","journal-title":"Alz Res Ther"},{"key":"1932_CR111","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41591-025-03622-w","volume":"31","author":"S Palmqvist","year":"2025","unstructured":"Palmqvist S, Warmenhoven N, Anastasi F, Pilotto A, Janelidze S, Tideman P, et al. Plasma phospho-tau217 for Alzheimer\u2019s disease diagnosis in primary and secondary care using a fully automated platform. Nat Med. 2025;31:2036\u201343. https:\/\/doi.org\/10.1038\/s41591-025-03622-w.","journal-title":"Nat Med"},{"key":"1932_CR112","doi-asserted-by":"publisher","unstructured":"Tan YJ, Mohammadi R, Saffari SE, Tan NI, Lim LS, Low SH, et al. Evaluating the real-world performance of plasma pTau217 and pTau181 in a Southeast Asian tertiary memory clinic. Cold Spring Harbor Laboratory; 2025. https:\/\/doi.org\/10.1101\/2025.05.22.25328192","DOI":"10.1101\/2025.05.22.25328192"},{"key":"1932_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12514","author":"Z Xiao","year":"2023","unstructured":"Xiao Z, Wu W, Ma X, Wu J, Liang X, Zhou X, et al. Plasma p\u2010tau217, p\u2010tau181, and NfL as early indicators of dementia risk in a community cohort: the Shanghai Aging Study. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2023. https:\/\/doi.org\/10.1002\/dad2.12514.","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"1932_CR114","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/alz.12706","volume":"19","author":"NC Cullen","year":"2023","unstructured":"Cullen NC, Janelidze S, Mattsson-Carlgren N, Palmqvist S, Bittner T, Suridjan I, et al. Test-retest variability of plasma biomarkers in Alzheimer\u2019s disease and its effects on clinical prediction models. Alzheimers Dement. 2023;19:797\u2013806. https:\/\/doi.org\/10.1002\/alz.12706.","journal-title":"Alzheimers Dement"},{"key":"1932_CR115","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/alz.13510","volume":"20","author":"RT Muir","year":"2024","unstructured":"Muir RT, Ismail Z, Black SE, Smith EE. Comparative methods for quantifying plasma biomarkers in Alzheimer\u2019s disease: implications for the next frontier in cerebral amyloid angiopathy diagnostics. Alzheimers Dement. 2024;20:1436\u201358. https:\/\/doi.org\/10.1002\/alz.13510.","journal-title":"Alzheimers Dement"},{"key":"1932_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2023.341535","volume":"1273","author":"M-V Tieu","year":"2023","unstructured":"Tieu M-V, Choi SH, Le HTN, Cho S. Electrochemical impedance-based biosensor for label-free determination of plasma P-tau181 levels for clinically accurate diagnosis of mild cognitive impairment and Alzheimer\u2019s disease. Anal Chim Acta. 2023;1273:341535. https:\/\/doi.org\/10.1016\/j.aca.2023.341535.","journal-title":"Anal Chim Acta"},{"key":"1932_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2024.114211","volume":"245","author":"J-S Ahn","year":"2025","unstructured":"Ahn J-S, Jang C-H. Real-time detection of Tau-381 protein using liquid crystal-based sensors for Alzheimer\u2019s disease diagnosis. Colloids Surf B Biointerfaces. 2025;245:114211. https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114211.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1932_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/adpr.202200044","author":"F Chiavaioli","year":"2022","unstructured":"Chiavaioli F, Santano Rivero D, Del Villar I, Socorro\u2010Ler\u00e1noz AB, Zhang X, Li K, et al. Ultrahigh sensitive detection of tau protein as Alzheimer\u2019s biomarker via microfluidics and nanofunctionalized optical fiber sensors. Advanced Photonics Research. 2022. https:\/\/doi.org\/10.1002\/adpr.202200044.","journal-title":"Advanced Photonics Research"},{"key":"1932_CR119","doi-asserted-by":"publisher","DOI":"10.1002\/admt.202500536","volume":"10","author":"FB Kamal Eddin","year":"2025","unstructured":"Kamal Eddin FB, Fan H, Liu Z, Donati P, Amin Y, Fen YW, et al. Progress in surface plasmon and other resonance biosensors for biomedical applications. Adv Mater Technol. 2025;10:2500536. https:\/\/doi.org\/10.1002\/admt.202500536.","journal-title":"Adv Mater Technol"},{"key":"1932_CR120","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.2147\/IJN.S521442","volume":"20","author":"C Mutalik","year":"2025","unstructured":"Mutalik C, Sharma S, Yougbar\u00e9 S, Chen C-Y, Kuo T-R. Nanoplasmonic biosensors: a comprehensive overview and future prospects. IJN. 2025;20:5817\u201336. https:\/\/doi.org\/10.2147\/IJN.S521442.","journal-title":"IJN"},{"key":"1932_CR121","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1109\/JLT.2024.3406581","volume":"42","author":"S Miyamura","year":"2024","unstructured":"Miyamura S, Higaki M, Taue S, Nakajima Y, Tokizane Y, Hase E, et al. Reduction of temperature drift in refractive-index-sensing optical frequency comb by active-dummy compensation of dual-comb configuration. J Lightwave Technol. 2024;42:6387\u201394. https:\/\/doi.org\/10.1109\/JLT.2024.3406581.","journal-title":"J Lightwave Technol"},{"key":"1932_CR122","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1021\/acssensors.4c03562","volume":"10","author":"MA Islam","year":"2025","unstructured":"Islam MA, Masson J-F. Plasmonic biosensors for health monitoring: inflammation biomarker detection. ACS Sens. 2025;10:577\u2013601. https:\/\/doi.org\/10.1021\/acssensors.4c03562.","journal-title":"ACS Sens"},{"key":"1932_CR123","doi-asserted-by":"publisher","first-page":"e78360","DOI":"10.7554\/eLife.78360","volume":"12","author":"E Cecon","year":"2023","unstructured":"Cecon E, Oishi A, Luka M, Ndiaye-Lobry D, Fran\u00e7ois A, Lescuyer M, et al. Novel repertoire of tau biosensors to monitor pathological tau transformation and seeding activity in living cells. Elife. 2023;12:e78360. https:\/\/doi.org\/10.7554\/eLife.78360.","journal-title":"Elife"},{"key":"1932_CR124","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.jalz.2019.06.4954","volume":"15","author":"CH Lo","year":"2019","unstructured":"Lo CH, Lim CK, Ding Z, Wickramasinghe SP, Braun AR, Ashe KH, et al. Targeting the ensemble of heterogeneous tau oligomers in cells: a novel small molecule screening platform for tauopathies. Alzheimers Dement. 2019;15:1489\u2013502. https:\/\/doi.org\/10.1016\/j.jalz.2019.06.4954.","journal-title":"Alzheimers Dement"},{"key":"1932_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10231","volume":"6","author":"CH Lo","year":"2021","unstructured":"Lo CH. Recent advances in cellular biosensor technology to investigate tau oligomerization. Bioeng Transl Med. 2021;6:e10231. https:\/\/doi.org\/10.1002\/btm2.10231.","journal-title":"Bioeng Transl Med"},{"key":"1932_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911527","volume":"23","author":"J Sala-Jarque","year":"2022","unstructured":"Sala-Jarque J, Zimkowska K, \u00c1vila J, Ferrer I, Del R\u00edo JA. Towards a mechanistic model of tau-mediated pathology in tauopathies: what can we learn from cell-based in vitro assays? Int J Mol Sci. 2022;23:11527. https:\/\/doi.org\/10.3390\/ijms231911527.","journal-title":"Int J Mol Sci"},{"key":"1932_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06840-z","author":"B Hurtle","year":"2024","unstructured":"Hurtle B, Donnelly CJ, Zhang X, Thathiah A. Live-cell visualization of tau aggregation in human neurons. Commun Biol. 2024. https:\/\/doi.org\/10.1038\/s42003-024-06840-z.","journal-title":"Commun Biol"},{"key":"1932_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01561-1","author":"M Arastoo","year":"2024","unstructured":"Arastoo M, Penny LK, Lofthouse R, Abdallah A, Abrahamsson A, Marini P, et al. High-affinity antibodies specific to the core region of the tau protein exhibit diagnostic and therapeutic potential for Alzheimer\u2019s disease. Alz Res Ther. 2024. https:\/\/doi.org\/10.1186\/s13195-024-01561-1.","journal-title":"Alz Res Ther"},{"key":"1932_CR129","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/mi15020181","volume":"15","author":"N Sitkov","year":"2024","unstructured":"Sitkov N, Ryabko A, Moshnikov V, Aleshin A, Kaplun D, Zimina T, et al. Hybrid impedimetric biosensors for express protein markers detection. Micromachines. 2024;15:181. https:\/\/doi.org\/10.3390\/mi15020181.","journal-title":"Micromachines"},{"key":"1932_CR130","doi-asserted-by":"publisher","first-page":"14314","DOI":"10.1021\/jacs.8b08645","volume":"140","author":"I-T Teng","year":"2018","unstructured":"Teng I-T, Li X, Yadikar HA, Yang Z, Li L, Lyu Y, et al. Identification and characterization of DNA aptamers specific for phosphorylation epitopes of Tau protein. J Am Chem Soc. 2018;140:14314\u201323. https:\/\/doi.org\/10.1021\/jacs.8b08645.","journal-title":"J Am Chem Soc"},{"key":"1932_CR131","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/bios9030084","volume":"9","author":"D Tao","year":"2019","unstructured":"Tao D, Shui B, Gu Y, Cheng J, Zhang W, Jaffrezic-Renault N, et al. Development of a label-free electrochemical aptasensor for the detection of Tau381 and its preliminary application in AD and non-AD patients\u2019 sera. Biosensors. 2019;9:84. https:\/\/doi.org\/10.3390\/bios9030084. MDPI AG.","journal-title":"Biosensors"},{"key":"1932_CR132","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1002\/cbic.202100287","volume":"22","author":"M Malhis","year":"2021","unstructured":"Malhis M, Kaniyappan S, Aillaud I, Chandupatla RR, Ramirez LM, Zweckstetter M, et al. Potent tau aggregation inhibitor D-peptides selected against tau-repeat 2 using mirror image phage display. Chembiochem. 2021;22:3049\u201359. https:\/\/doi.org\/10.1002\/cbic.202100287.","journal-title":"Chembiochem"},{"key":"1932_CR133","doi-asserted-by":"publisher","unstructured":"Aillaud I, Kaniyappan S, Chandupatla RR, Ramirez LM, Alkhashrom S, Eichler J, et al. A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro. Alz Res Ther. 2022. https:\/\/doi.org\/10.1186\/s13195-022-00959-z.","DOI":"10.1186\/s13195-022-00959-z"},{"key":"1932_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2022.114935","volume":"222","author":"L Zhang","year":"2023","unstructured":"Zhang L, Cao K, Su Y, Hu S, Liang X, Luo Q, et al. Colorimetric and surface-enhanced raman scattering dual-mode magnetic immunosensor for ultrasensitive detection of blood phosphorylated tau in Alzheimer\u2019s disease. Biosens Bioelectron. 2023;222:114935. https:\/\/doi.org\/10.1016\/j.bios.2022.114935.","journal-title":"Biosens Bioelectron"},{"key":"1932_CR135","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/molecules27020431","volume":"27","author":"R Jalili","year":"2022","unstructured":"Jalili R, Chenaghlou S, Khataee A, Khalilzadeh B, Rashidi M-R. An electrochemiluminescence biosensor for the detection of Alzheimer\u2019s tau protein based on gold nanostar decorated carbon nitride nanosheets. Molecules. 2022;27:431. https:\/\/doi.org\/10.3390\/molecules27020431. MDPI AG.","journal-title":"Molecules"},{"key":"1932_CR136","doi-asserted-by":"publisher","unstructured":"Kim JH, Shin JH, Park B, Cho CH, Huh YS, Choi C-H, et al. Harnessing protein sensing ability of electrochemical biosensors via a controlled peptide receptor\u2013electrode interface. J Nanobiotechnology. 2023. https:\/\/doi.org\/10.1186\/s12951-023-01843-0.","DOI":"10.1186\/s12951-023-01843-0"},{"key":"1932_CR137","doi-asserted-by":"publisher","first-page":"7225","DOI":"10.1007\/s00216-024-05294-w","volume":"416","author":"S Campuzano","year":"2024","unstructured":"Campuzano S, Pedrero M, Barderas R, Pingarr\u00f3n JM. Breaking barriers in electrochemical biosensing using bioinspired peptide and phage probes. Anal Bioanal Chem. 2024;416:7225\u201347. https:\/\/doi.org\/10.1007\/s00216-024-05294-w.","journal-title":"Anal Bioanal Chem"},{"key":"1932_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024948","volume":"6","author":"J Wu","year":"2011","unstructured":"Wu J, Park JP, Dooley K, Cropek DM, West AC, Banta S, et al. Rapid development of new protein biosensors utilizing peptides obtained via phage display. PLoS One. 2011;6:e24948. https:\/\/doi.org\/10.1371\/journal.pone.0024948.","journal-title":"PLoS One"},{"key":"1932_CR139","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/10826068.2018.1466154","volume":"48","author":"HJ Shin","year":"2018","unstructured":"Shin HJ, Lim WK. Rapid label-free detection of E. coli using a novel SPR biosensor containing a fragment of tail protein from phage lambda. Prep Biochem Biotechnol. 2018;48:498\u2013505. https:\/\/doi.org\/10.1080\/10826068.2018.1466154.","journal-title":"Prep Biochem Biotechnol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01932-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01932-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01932-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T12:19:21Z","timestamp":1767874761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-025-01932-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":139,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1932"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01932-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have consented for this review paper to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}